Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

TaiGen Raises $36 Million in Taiwan IPO

publication date: Jan 20, 2014
TaiGen Biotechnology, a Taiwan biopharma with a Beijing subsidiary, completed a $35.7 million IPO on Taiwan’s GreTai market. The company’s shares rose 6% in the first trading session, giving TaiGen a valuation of $1.1 billion. TaiGen said it would use the capital to advance its discovery and development pipeline. TaiGen has raised a total of $131 million in venture capital since it was founded in 2001. More details....

Stock Symbol: (TWO: 4157)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China